Clinical research

Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients

EuroIntervention 2012;8:717-723. DOI: 10.4244/EIJV8I6A111

Corinna Heinisch
Corinna Heinisch, MD; Stefan Bertog, MD; Nina Wunderlich, MD; Nico Majunke, MD; Andreas Baranowski, MD; Michaela Leetz, MD; Evelyne Fischer, MD; Stefan Staubach, MD; Wibke Zimmermann, MD; Ilona Hofmann, MD; Horst Sievert*, MD
CardioVascular Center, Frankfurt, Germany

Aims: Although routinely used, limited data are available regarding the long-term outcome after patent foramen ovale (PFO) closure using the HEL

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

patent foramen ovalehelex<span class="exposant">®</span> occluder systempercutaneous closurelong-term results
Read next article
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial

Latest news